1. Home
  2. ABP vs SYNX Comparison

ABP vs SYNX Comparison

Compare ABP & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • SYNX
  • Stock Information
  • Founded
  • ABP 2004
  • SYNX 2005
  • Country
  • ABP United States
  • SYNX Israel
  • Employees
  • ABP N/A
  • SYNX N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • SYNX
  • Sector
  • ABP Health Care
  • SYNX
  • Exchange
  • ABP Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • ABP 12.3M
  • SYNX 11.4M
  • IPO Year
  • ABP N/A
  • SYNX 2024
  • Fundamental
  • Price
  • ABP $0.27
  • SYNX $1.72
  • Analyst Decision
  • ABP Strong Buy
  • SYNX
  • Analyst Count
  • ABP 1
  • SYNX 0
  • Target Price
  • ABP $4.00
  • SYNX N/A
  • AVG Volume (30 Days)
  • ABP 16.7M
  • SYNX 90.5K
  • Earning Date
  • ABP 08-13-2025
  • SYNX 10-02-2025
  • Dividend Yield
  • ABP N/A
  • SYNX N/A
  • EPS Growth
  • ABP N/A
  • SYNX N/A
  • EPS
  • ABP N/A
  • SYNX N/A
  • Revenue
  • ABP $183,000.00
  • SYNX $9,094,000.00
  • Revenue This Year
  • ABP N/A
  • SYNX $32.35
  • Revenue Next Year
  • ABP N/A
  • SYNX N/A
  • P/E Ratio
  • ABP N/A
  • SYNX N/A
  • Revenue Growth
  • ABP 154.17
  • SYNX 19.14
  • 52 Week Low
  • ABP $0.15
  • SYNX $1.50
  • 52 Week High
  • ABP $11.19
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • SYNX 46.62
  • Support Level
  • ABP N/A
  • SYNX $1.54
  • Resistance Level
  • ABP N/A
  • SYNX $1.79
  • Average True Range (ATR)
  • ABP 0.00
  • SYNX 0.14
  • MACD
  • ABP 0.00
  • SYNX -0.00
  • Stochastic Oscillator
  • ABP 0.00
  • SYNX 52.52

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: